NEWSWIRETODAY Press Release& Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Written by / Agency / Source: Withings
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Withings Acquires Impeto Medical to Strengthen and Grow its Research and Development of Medical Technologies - Leader in the tracking of peripheral neuropathies, acquired by pioneers of connected health - Impeto-Medical.com / Withings.com
Withings Acquires Impeto Medical to Strengthen and Grow its Research and Development of Medical Technologies

 

NewswireToday - /newswire/ - Issy les Moulineaux, Hauts-de-Seine, France, 2022/01/14 - Leader in the tracking of peripheral neuropathies, acquired by pioneers of connected health - Impeto-Medical.com / Withings.com .

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services / Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Withings, the pioneer of the connected health movement, has announced the acquisition of Impeto Medical (impeto-medical.com), a specialist in R&D, manufacturing and distribu7on of innova7ve medical devices for physicians.

This announcement incorporates the ownership of Impeto’s SUDOSCAN® technology, a leader in detec7ng and tracking peripheral neuropathies. The procurement will strengthen the research and development of new technologies for future Withings health products and services.

Established in 2005, Impeto Medical set new standards in detec7ng and tracking small fiber neuropathy - damage or dysfunc7on of small nerves - leveraging its proprietary SUDOSCAN® technology. The FDA cleared solu7on measures the ability of the sweat glands to release chloride ions in response to an electrical s7mulus on the palms of the hands and soles of the feet. The degenera7on of small nerve fibers reduces sweat gland innerva7on and impairs sudomotor func7on. SUDOSCAN®efficacy has been evaluated in the assessment of small fiber peripheral neuropathies in several diseases states, including diabetes, Chemotherapy-induced polyneuropathy, family amyloid polyneuropathy, and Fabry disease compared to gold-standard reference tests such as Skin biopsy or Quan7ta7ve Sudomotor Axon Reflex Test( QSART). Its solu7on has been licensed and embedded into of thousands of devices for pharmacies, medical offices and hospitals worldwide.

“We are delighted to announce the acquisi9on of Impeto Medical as we welcome its experience and technologies into the Withings por?olio. The company and its team have been important partners to us in the past. Now, as part of Withings, we have an exci9ng opportunity to con9nue to deploy together their exper9se and Sudoscan technology in the development of a variety of devices that have the poten9al for people to monitor and manage various disease states from the comfort of their home” said Mathieu Letombe, Withings CEO.

The first Withings product to incorporate SUDOSCAN® technology will be Withings Body Scan recently announced during CES 2022. Following FDA clearance, Body Scan will provide at home analysis of biomarkers associated with common health condi7ons. With the ability to monitor segmental body composi7on, heart rate, and vascular age, it will further advance the smart scale category. With measurements that will assess nerve ac7vity and heart rhythm using a 6-lead ECG, Body Scan goes beyond weight management to become an unprecedented in-home connected health sta7on that can help users take proac7ve measures.

As part of the deal, Withings has acquired all Impeto technology IP and patent. Impeto Medical staff has become a full part of Withings. Exis7ng Impeto Medical customers will con7nue to be provided
with full support.

About Withings

Established in 2008, Withings (withings.com), is a world leader in connected health technology. Its team of engineers, data scien7sts, and healthcare professionals have enthused everyday, elegant lifestyle objects with medical and wellness capabili7es to efficiently track health vitals. Its range of in-home devices can monitor more than 20 health parameters and are used daily by millions of people worldwide. Its porbolio of devices includes connected scales, hybrid watches, smart thermometers, blood pressure monitors, and sleep trackers to empower individuals to take back control of their health and track medical and wellness data.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services / Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Withings

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services / Equipment articles,
CATCH Visitors via Your Competitors Announcements!


Withings Acquires Impeto Medical to Strengthen and Grow its Research and Development of Medical Technologies

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
Publisher Contact: Press Office - Withings.com 
+33(0)1 41 46 04 60 press[.]withings.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Withings securities in any jurisdiction including any other companies listed or named in this release.

Medical Services / Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Withings / Company Profile


Read Medical Services / Equipment Most Recent Related Newswires:

LifeOmic Applauded by Frost & Sullivan for Enabling More Cost-efficient, Targeted Holistic Precision Health with its Interoperable Precision Health So
Bruker and TOFWERK Form Strategic Partnership in High-Speed, Ultra-Sensitive Solutions for Applied and Industrial Markets
Bruker Launches Novel 7 Tesla and 9.4 Tesla Preclinical MRI Magnets
Withings Health Solutions Brings Simplicity and Enhanced Patient Experience to the Core of its New Enhanced Remote Patient Monitoring Solution
Bruker Launches Minispec Droplet Size Analyzer 2.0 for Food and Cosmetic Applications
Bruker Advances Biomolecular Research with GHz-Class NMR Announces New Capabilities for High-Performance Fourier 80
Bruker Demonstrates Novel and Unique Compact 1.0 GHz NMR Magnet
Bruker Announces Key Innovations for Multiplexed Spatial Proteomics and Unbiased Multiomic Imaging for Cancer Research
Bruker Launches Benchtop FT-NMR Solution for Forensic Narcotics Analysis
Bruker Acquires Optimal Companies for Pharma PAT Software and Biopharma Manufacturing Automation Expertise and Technologies
IBA and Tractebel Agree on Partnership to Support Proton Therapy Construction Projects
SCHOTT and Hungarian Government Invest in Cutting-edge Syringe Production
Bruker Releases CCS-Enabled TIMScore™ and TIMS DIA-NN 4D Proteomics Software
C2i Genomics Applauded by Frost & Sullivan for Enabling Real-time Cancer Monitoring Using Genomic Data with its C2intelligence Platform
XACT Robotics® Lauded by Frost & Sullivan for Improving CT-guided Percutaneous Procedures with its Breakthrough Hands-Free Robotic System

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Limelon Advertising, Co.

Visit  BizJobs.com





 
  ©2022 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are proudly NOT affiliated with USA TODAY (usatoday.com)